The impact of Covid-19 in Chhattisgarh, India: A descriptive study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 38482304.
- Also identified by DOI 10.4103/jfmpc.jfmpc_1012_23 and PMC identifier 10931895.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
India is among the most severely affected countries in the ongoing Covid-19 pandemic, second to the USA. Until July 2022, there were 43 million confirmed Covid-19 cases, with 0.53 million Covid-19 deaths in India. Chhattisgarh, the twelfth-highest affected state by Covid-19 disease, has had an enormous mortality toll, with 14,046 deaths by 15<sup>th</sup> July 2022. This study is a descriptive analysis of the Covid-19 deaths across Chhattisgarh from September 2021 to February 2022 (the third pandemic wave). All Covid-19 deaths that occurred between September 2021 to February 2022 were line-listed, and family members of all who died in the hospital were interviewed. 356 Covid-19 deaths were included in the present study. The top three districts which observed maximum deaths (63.48%) were Raipur (27.53%), Durg (15.45%), and Bilaspur (7.87%). Around 50% of the deceased were of age 65 years or above. The male deaths were twice as compared to the female deaths. The RT-PCR was the most used testing method, followed by RAT. Most of the admissions (58%) were in a government facility. Among the deceased, 60% had one or two associated comorbidities. Hypertension and Diabetes were the most common comorbidity identified. Almost 90% of patients were symptomatic. Breathlessness was the most common symptom. Half of the deceased were not vaccinated. The median expenditure on Covid-19 management was ₹ 50,000 (€ 565.13). The deaths in the study were urban-centric. Higher Covid-19 mortality was observed in unvaccinated older men (≥65 years) with one or more comorbidity.